It inhibits the activity of target enzymes/factors located in tumour cells (CRAF, BRAF, V600E BRAF, c-KIT and FLT-3) and in tumour vasculature (CRAF, VEGFR-2, VEGFR-3 and PDGFR-β) [2]. This evidence concerns the gene FLT3 and neoplasm.